Cover
Cover | Nov. 24, 2021 | Jun. 14, 2021 |
Cover [Abstract] | ||
Document Type | 8-K | |
Amendment Flag | false | |
Document Period End Date | Nov. 24, 2021 | |
Entity File Number | 000-22245 | |
Entity Registrant Name | Seelos Therapeutics, Inc. | |
Entity Central Index Key | 0001017491 | |
Entity Tax Identification Number | 87-0449967 | |
Entity Incorporation, State or Country Code | NV | |
Entity Address, Address Line One | 300 Park Avenue | |
Entity Address, Address Line Two | 2nd Floor | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10022 | |
City Area Code | (646) | |
Local Phone Number | 293-2100 | |
Written Communications | false | |
Soliciting Material | false | |
Pre-commencement Tender Offer | false | |
Pre-commencement Issuer Tender Offer | false | |
Title of 12(b) Security | Common Stock, $0.001 par value | |
Trading Symbol | SEEL | |
Security Exchange Name | NASDAQ | |
Entity Emerging Growth Company | false |